Karakteristika hos patienten Køn Der blev ikke observeret nogen klinisk relevante forskelle i vildagliptins farmakokinetik hos mandlige og kvindelige forsøgspersoner inden for et bredt interval af alder og BMI.
Characteristics in patients Gender No clinically relevant differences in the pharmacokinetics of vildagliptin were observed between male and female healthy subjects within a wide range of age and body mass index (BMI).